Dipyridamole stress echocardiography and ultrasonic myocardial tissue characterization in predicting myocardial ischemia, in comparison with dipyridamole stress Tc-99m MIBI SPECT myocardial imaging

Japanese Heart Journal

Volumn 45, Issue 6, 2004, Pages 937-948

  Onbasili, Osman Alper ^a   Erdogan, Serpil ^a   Tekten, Tarkan ^a   Ceyhan, Ceyhun ^a   Yurekli, Yakup ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Dipyridamole stress; Myocardial ischemia; Ultrasonic tissue characterization

Indexed keywords

AMINOPHYLLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; FLUSHING; HEADACHE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE WALL MOTION; HUMAN; HYPERTENSION; HYPOTENSION; INTERMETHOD COMPARISON; MALE; PREDICTION; PRIORITY JOURNAL; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE; STRESS ECHOCARDIOGRAPHY; THORAX PAIN; TISSUE CHARACTERIZATION; COMPARATIVE STUDY; ECHOGRAPHY; HEART; HEART CONTRACTION; MIDDLE AGED; RADIOGRAPHY; SCINTISCANNING; VALIDATION STUDY;

AGED; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIPYRIDAMOLE; ECHOCARDIOGRAPHY, STRESS; HEART; HUMANS; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 13844312871     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.45.937     Document Type: Article

References (37)

1. Gould KL. Pharmacologic intervention as an alternative to exercise stress. Semin Nucl Med 1987; 17: 121-30.
2. Iskandrian AS, Heo J, Askenase A, Segal BL, Auerbach N. Dipyridamole cardiac imaging. Am Heart J 1988; 114: 432-43.
3. Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. Usefulness of the dipyridamole-exercise echocardiography test for diagnosis of coronary artery disease. Am J Cardiol 1988; 62: 67-70.
4. Margonato A, Chierchia S, Cianflone D, et al. Limitations of dipyridamole echocardiography in effort angina pectoris. Am J Cardiol 1987; 59: 225-30.
5. Miller JG, Perez JE, Sobel BE. Ultrasonic tissue characterization of myocardium. Prog Cardiovasc Dis 1985; 18: 85-110.
6. Perez JE, Miller JG. Ultrasonic backscatter tissue characterization in cardiac diagnosis. Clin Cardiol 1991; 14: 4-9.
7. Milunski MR, Mohr GA, Wear KA, Sobel BE, Miller JG, Wickline SA. Early identification with ultrasonic integrated backscatter of viable but stunned myocardium in dogs. J Am Coll Cardiol 1989; 14: 462-71.
8. Sagar KB, Rhyne TL, Warltier DC, Pele LE, Wann LS. Intramyocardial variability in integrated backscatter: effect of coronary occlusion and reperfusion. Circulation 1987; 75: 436-43.
9. Takiuchi S, Ito H, Iwakura K, et al. Ultrasonic tissue characterization predicts myocardial viability in early stage of reperfused acute myocardial infarction. Circulation 1998; 97: 356-62.
10. Goens MB, Karr SS, Martin GR. Cyclic variation of integrated ultrasound backscatter: normal and abnormal myocardial patterns in children. J Am Soc Echocardiogr 1996; 9: 616-21.
11. Henry WL, De Maria A, Gramiak R, et al. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation 1980; 62: 212-7.
12. Cerqueira MD, Weissman NJ, Dilsizian V, et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. J Am Soc Echocardiogr 2002; 15: 464-8.
13. Ferrara N, Bonaduce D, Leosco D, et al. Two-dimensional echocardiographic evaluation of ventricular asynergy induced by dipyridamole: correlation with thallium scanning. Clin Cardiol 1986; 9: 437-43.
14. Parodi G, Picano E, Marcassa C, et al. High dose dipyridamole stress imaging: Comparison of sestamibi scintigraphy and 2D-echocardiography for evaluation of the extent and severity of coronary artery. Coron Artery Dis 1999; 10: 177-84.
15. Perin EC, Moore W, Blume M, Hernandez G, Dhekne R, DeCastro CM. Comparison of dipyridamole echocardiography with dipyridamole thallium scintigraphy for the diagnosis of myocardial ischemia. Clin Nucl Med 1991; 16: 417-20.
16. Santoro GM, Sciagra R, Buonamici P, et al. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease. J Nucl Cardiol 1998; 5: 19-27.
17. Schilaci O, Moroni C, Scopinaro F, et al. Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain. Eur J Nucl Med 1997; 7: 774-82.
18. Dagianti A, Penco M, Agati L, et al. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 1995; 26: 18-25.
19. Casanova R, Patroncini A, Guidalotti PL, et al. Dose and test for dipyridamole infusion and cardiac imaging early after uncomplicated acute myocardial infarction. Am J Cardiol 1992; 70: 1402-6.
20. Cortigiani L, Paolini EA, Nannini E. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain. Circulation 1998; 98: 2855-59.
21. Beller GA. Pharmacologic stress imaging. JAMA 1991; 265: 633-8.
22. Madras EI, Barzilai B, Perez JE, Miller JG. Changes in myocardial backscatter throughout the cardiac cycle. Ultrason Imaging 1983; 5: 229-9.
23. Barzilai B, Madaras EI, Sobel BE, Miller JG, Perez EJ. Effects of myocardial contraction on ultrasonic back-scatter before and after ischemia. Am J Physiol 1994; 247: 478-83.
24. Wickline SA, Thomas LJ 3rd, Miller JG, Sobel BE, Perez JE. The dependence of myocardial ultrasonic integrated backscatter on contractile performance. Circulation 1985; 72: 183-92.
25. Wickline SA, Thomas LJ 3rd, Miller JG, Sobel BE, Perez JE. Sensitive detection of the effect of reperfasion on myocardium by ultrasonic tissue characterization with the integrated backscatter. Circulation 1986; 74: 389-400.
26. Glueck RM, Mottley JG, Miller JG, Sobel BE, Perez JE. Effects of coronary artery occlusion and reperfusion on cardiac cycle-dependent variation of myocardial ultrasonic backscatter. Circ Res 1985; 56: 683-9.
27. Sagar KB, Pele LE, Rhyne TL, Wann LS, Waltier DC. Influence of heart rate, preload, afterload, and inotropic state on myocardial ultrasonic backscatter. Circulation 1988; 77: 478-83.
28. Mimbs JW, Bauwenx D, Cohen RD, O'Donnell M, Miller JG, Sobel BE. Effects of myocardial ischemia on quantitative ultrasonic backscatter and identification of responsible determinants. Circ Res 1981; 49: 89-96.
29. Schnittger I, Vieli A, Heiserman JE, et al. Ultrasonic tissue characterization: detection of acute myocardial ischemia in dogs. Circulation 1985; 72: 193-9.
30. Milunski MR, Mohr GA, Wear KA, Sobel BE, Miller JG, Wickline SA. Early identification with ultrasonic integrated backscatter of viable but stunned myocardium in dogs. J Am Coll Cardiol 1989; 14: 462-71.
31. Tekten T, Onbasili AO, Ceyhan C, Discigil B. Cyclic variation of myocardial integrated backscatter and myocardial wall thickness during percutaneous coronary angioplasty. Echocardiography 2003; 20: 423-8.
32. Lin LC, Ho YL, Wu CC, et al. Comparison of simultaneous dobutamine echocardiography and thallium-201 stress-reinjection single-photon emission computed tomography in predicting improvement of chronic myocardial dysfunction after revascularization. Am J Cardiol 2000; 86: 293-8.
33. Vitale DF, Bonow RO, Gerundo G, et al. Alterations in ultrasonic backscatter during exercise-induced myocardial ischemia in humans. Circulation 1995; 92: 1452-7.
34. Milunski MR, Mohr GA, Perez JE, et al. Ultrasonic tissue characterization with integrated backscatter. Acute myocardial ischemia, reperfusion, and stunned myocardium in patients. Circulation 1989; 80: 491-503.
35. Kaprielian RR, Gunning M, Dupont E, et al. Downregulation of immundetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 1998; 97: 651-60.
36. Picano E, Faletra F, Marini C, et al. Increased echodensity of transiently asynergic myocardium in humans: a novel echocardiographic sign of myocardial ischemia. J Am Coll Cardiol 1993; 21: 199-207.
37. Hall CS, Verdonk ED, Wickline SA, Perez JE, Miller JG. Anisotropy of the apparent frequency dependence of backscatter in formalin fixed human myocardium. J Acoust Soc Am 1997; 101: 563-8.